Active, not recruitingPhase 1NCT03101891
Renal Anhydramnios Fetal Therapy
Studying Bilateral multicystic dysplastic kidney
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Meredith Atkinson, M.DJohns Hopkins University
- Intervention
- Serial amnioinfusions with isotonic fluid(procedure)
- Enrollment
- 70 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2018 – 2030
Study locations (9)
- University of Southern California/Children's Hospital of Los Angeles/Huntington Hospital, Los Angeles, California, United States
- University of California San Francisco, San Francisco, California, United States
- Stanford University, Stanford, California, United States
- University of Colorado Denver, Aurora, Colorado, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Columbia University, New York, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center at Houston, Houston, Texas, United States
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03101891 on ClinicalTrials.govOther trials for Bilateral multicystic dysplastic kidney
Additional recruiting or active studies for the same condition.
See all trials for Bilateral multicystic dysplastic kidney →